The piece of writing highlights what clinicians need to know for the identification of women at high risk of hereditary cancers. Genetic mutations can put them at risk for reproductive cancers such as endometrial, breast and ovarian and the a better chance of survival is possible with enhanced screenings and other risk-reduction methods.